After a survival analysis, and drug–target–pathway analysis, five hub genes (HSP90AA1, ESR1, CYP3A4, CDK1, and MMP9) were discovered to be involved in the overall survival of LC patients. The gene discussed is CYP3A4; the disease is laryngotracheoesophageal cleft.